← Back
$COGT All transactions

Cogent Biosciences, Inc.

▲ BUY
10 / 10

Conviction

$ Value

$25.0M

Shares

2,777,777

Price

$9

Filed

Jul 14

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Fairmount Funds Management LLC

Title

CIK

0001802528

Roles

Director

Transaction Details

Transaction Date

2025-07-10

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

9,003,418

Footnotes

Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Filing Info

Accession No.

0001104659-25-067758

Form Type

4

Issuer CIK

0001622229

Fairmount Funds Management LLC's History

Date Ticker Type Value
2026-03-31 COGT C
2026-03-31 COGT $242.6M
2026-03-31 COGT C $0
2026-03-31 ZBIO $3.0M
2026-03-23 DMRA A $0
2026-01-22 APGE $133.5M
2026-01-22 COGT $127.4M
2025-12-04 CBIO $18.2M
2025-12-04 CBIO $1.8M
2025-10-23 VRDN $10.0M

Other Insiders at COGT (90d)

Insider Bought Sold Last
Ferrante Karen Jean 2026-04-01
Fairmount Funds Management LLC $242.6M 2026-03-31